After Hours Summary: SHAK +6%, PBR +1%, DDS-6% following earnings/guidance; TTPH -24% following guidance from FDAAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: HTGM +34.9% (enters into research collaboration with Bristol-Myers Squibb (BMY) to evaluate the potential for immuno-oncology molecular profiling in multiple tumor types), RUN +15.4%, KMPH +8.9%, NVDA +7.4%, SHAK +6.2%, PBR +1.2%
Companies trading higher in after hours in reaction to news: CLBS +11.4% (confirms it was granted orphan designation by the FDA for its compound for the treatment of type 1 diabetes mellitus with residual beta cell function)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CFMS -37.9%, JWN -17.4%, VJET -11.6%, DDS -5.8%, DAR -5.4%, ANY -5%, GEVO -6.3%, ARGS -4.4%
Companies trading lower in after hours in reaction to news: TTPH -23.9% (receives guidance from the FDA regarding the regulatory path for eravacycline; FDA advises that data from one additional positive phase 3 clinical trial will be required to support an NDA submission), ECC -7.6% (to commence 1.25 mln share public offering of common stock), NFLX -1% (California Public Employees' Retirement System (CalPERS) and the New York City Pension Funds request shareowners vote for non-binding proposal to give shareowners effective access to the director nomination process)